Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QIV-IB in Infants and Children
NCT05779020Phase 3Completed
- Sponsor
- Instituto Butantan
- Start
- Apr 2023
- Primary completion
- Sep 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of QIV-IB in influenza, sponsored by Instituto Butantan. Started Apr 2023; status: completed.
02
Drugs
QIV-IB
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05779020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05779020.